Cited by 1,385Cardiovascular Health and Disease PreventionCardiac Imaging and DiagnosticsNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Prognostic Value of Coronary Vascular Endothelial Dysfunction

Halcox, Julian P.J., Schenke, William H., Zalos, Gloria, Mincemoyer, Rita, Prasad, Abhiram, Waclawiw, Myron A., Nour, Khaled R.A., Quyyumi, Arshed A.·2002·Circulation

DOI 10.1161/01.cir.0000025404.78001.d8

Open this paper in CoChat — free account

Abstract

Background — Whether patients at increased risk can be identified from a relatively low-risk population by coronary vascular function testing remains unknown. We investigated the relationship between coronary endothelial function and the occurrence of acute unpredictable cardiovascular events (cardiovascular death, myocardial infarction, stroke, and unstable angina) in patients with and without coronary atherosclerosis (CAD). Methods and Results — We measured the change in coronary vascular resistance (ΔCVR) and epicardial diameter with intracoronary acetylcholine (ACh, 15 μg/min) to test endothelium-dependent function and sodium nitroprusside (20 μg/min) and adenosine (2.2 mg/min) to test endothelium-independent vascular function in 308 patients undergoing cardiac catheterization (132 with and 176 without CAD). Patients underwent clinical follow-up for a mean of 46±3 months. Acute vascular events occurred in 35 patients. After multivariate analysis that included CAD and conventional risk factors for atherosclerosis, ΔCVR with ACh ( P =0.02) and epicardial constriction with ACh ( P =0.003), together with increasing age, CAD, and body mass index, were independent predictors of adverse events. Thus, patients in the tertile with the best microvascular responses with ACh and those with epicardial dilation with ACh had improved survival by Kaplan-Meier analyses in the total population, as did those in the subset without CAD. Similar improvement in survival was also observed when all adverse events, including revascularization, were considered. Endothelium-independent responses were not predictive of outcome. Conclusions — Epicardial and microvascular coronary endothelial dysfunction independently predict acute cardiovascular events in patients with and without CAD, providing both functional and prognostic information that complements angiographic and risk factor assessment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000025404.78001.d8

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
SAS user's guide
Barr, A. J. (1979) · Medical Entomology and Zoology · Cited by 7,198
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,537

Show all 24 references

Research works printed but not linked: 7

10.1161/circ.101.16.1899 · DOI
10.1161/circ.101.9.948 · DOI
10.1161/res.87.10.840 · DOI
10.1161/circ.103.15.1936 · DOI
10.1161/atvb.17.12.3376 · DOI
10.1161/circ.98.1.17 · DOI
1994, Lancet, 344, 1383

Sorted by citations

Items 101–200 of 999

Exercise Training in Obese Children and Adolescents
Watts, K., Jones, T. W., Davis, E. A., & GREEN, D. J. (2005) · Sports Medicine · doi:10.2165/00007256-200535050-00002 · Cited by 237
Grapes and Cardiovascular Disease
Dohadwala, M. M., & Vita, J. A. (2009) · Journal of Nutrition · doi:10.3945/jn.109.107474 · Cited by 240
“Furthermore, endothelial dysfunction predicts progression of atherosclerosis and incidence of cardiovascular events (46,47).”
Background
The metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 233
“The latter is the first step in the atherosclerotic process (73) and can predict subsequent clinical vascular events (74,75).”
Background
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease
Shechter, M., Issachar, A., Marai, I., Koren‐Morag, N., Freinark, D., Shahar, Y., Shechter, A., & Feinberg, M. S. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.01.021 · Cited by 231
l-Citrulline Supplementation: Impact on Cardiometabolic Health
Allerton, T. D., Proctor, D. N., Stephens, J. M., Dugas, T. R., Spielmann, G., & Irving, B. A. (2018) · Nutrients · doi:10.3390/nu10070921 · Cited by 251
Aerobic exercise training and vascular function with ageing in healthy men and women
Seals, D. R., Nagy, E., & Moreau, K. L. (2019) · The Journal of Physiology · doi:10.1113/jp277764 · Cited by 231
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti–tumor necrosis factor α antibody
González‐Juanatey, C., Testa, A., García‐Castelo, A., Garcı́a-Porrúa, C., Llorca, J., & González-Gay, M. Á. (2004) · Arthritis Care & Research · doi:10.1002/art.20407 · Cited by 227
Coronary microvascular dysfunction in the clinical setting: from mystery to reality
Herrmann, J., Kaski, J. C., & Lerman, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs246 · Cited by 227
“higher risk of developing cardiovascular events during follow-up, regardless of the presence or absence of obstructive epicardial coronary artery stenoses.(86,87) With the caveats outlined above, an abnormal CFR seems to be a marker of a worse long-term outcome including a .”
Background
Translation of High-Density Lipoprotein Function Into Clinical Practice
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P. J., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2013) · Circulation · doi:10.1161/circulationaha.113.000962 · Cited by 225
“endothelium-dependent and endothelium-independent vascular function.(57,58) In a prospective study, both endothelium-dependent”
Background
Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation
Pries, A. R., Badimón, L., Bugiardini, R., Camici, P. G., Dorobanţu, M., Duncker, D. J., Escaned, J., Koller, Á., Piek, J. J., & de Wit, C. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv100 · Cited by 228
The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort
Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., Boden-Albala, B., Sacco, R., & Homma, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.005 · Cited by 219
“[6] Halcox JP, Schenke WH, Zalos G, et al.”
Background
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
AlBadri, A., Merz, C. N. B., Johnson, B. D., Wei, J., Mehta, P. K., Cook‐Wiens, G., Reís, S. E., Kelsey, S. F., Bittner, V., Sopko, G. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.040 · Cited by 220
“This is in line with multiple previous reports which also failed to show an association (11,20).”
Result
Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease
Wei, J., Mehta, P. K., Johnson, B. D., Samuels, B. A., Kar, S., Anderson, R. D., Azarbal, B., Petersen, J. W., Sharaf, B. L., Handberg, E. M., et al. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.01.023 · Cited by 219
Digital Assessment of Endothelial Function and Ischemic Heart Disease in Women
Matsuzawa, Y., Sugiyama, S., Sugamura, K., Nozaki, T., Ohba, K., Konishi, M., Matsubara, J., Sumida, H., Kaikita, K., Kojima, S., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.073 · Cited by 219
Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging
Fukushima, K., Javadi, M. S., Higuchi, T., Läutamaki, R., Merrill, J., Nekolla, S. G., & Bengel, F. M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.081828 · Cited by 219
“Age (y) 57 6 12 58 6 13 Sex Men 112 (40) 86 (38) Women 163 (60) 138 (62) Race White 82 (30) 61 (27) Black 181 (66) 159 (71) Other 12 (4) 4 (2) Body mass index (kg/m2) 32 6 9 32 6 9 Known CAD 91 (33) 87 (39) History of prior myocardial infarction 30 (11) 26 (12) Pretest CAD likelihood* Low 101 (37) 82 (37) Intermediate…”
Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity
Haram, P. M., Kemi, O. J., Lee, S. J., Bendheim, M. Ø., Al–Share, Q. Y., Waldum, H. L., Gilligan, L. J., Koch, L. G., Britton, S. L., Najjar, S. M., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn332 · Cited by 227
“Antecedent exploration and the current results show that this rat model exhibits compromised insulin action in fat tissue and the liver and an abnormal metabolic state.(5) Regular exercise training was able to improve insulin action, with a stronger effect of high- vs.”
BackgroundResult
Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease
Sen, S., McDonald, S. P., Coates, P. T., & Bonder, C. S. (2010) · Clinical Science · doi:10.1042/cs20100429 · Cited by 213
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial
Lüscher, T. F., Taddei, S., Kaski, J. C., Jukema, J. W., Kallend, D. G., Münzel, T. F., Kastelein, J. J. P., & Deanfield, J. E. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs019 · Cited by 217
Angiotensin II Induces Endothelial Xanthine Oxidase Activation: Role for Endothelial Dysfunction in Patients With Coronary Disease
Landmesser, U., Spiekermann, S., Preuss, C., Sorrentino, S., Fischer, D., Manes, C., Mueller, M., & Drexler, H. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258415.32883.bf · Cited by 210
Endothelial Progenitor Cells During Cerebrovascular Disease
Ghani, U., Shuaib, A. M., Salam, A., Nasir, A., Shuaib, U., Jeerakathil, T., Sher, F., O’Rourke, F., Nasser, A. M., Schwindt, B., et al. (2004) · Stroke · doi:10.1161/01.str.0000149944.15406.16 · Cited by 209
Impaired Flow-Mediated Dilation and Risk of Restenosis in Patients Undergoing Coronary Stent Implantation
Patti, G., Pasceri, V., Melfi, R., Goffredo, C., Chello, M., D’Ambrosio, A., Montesanti, R., & Sciascio, G. D. (2005) · Circulation · doi:10.1161/01.cir.0000151308.06673.d2 · Cited by 207
Flavonoids: Antioxidants Against Atherosclerosis
Grassi, D., Desideri, G., & Ferri, C. (2010) · Nutrients · doi:10.3390/nu2080889 · Cited by 205
“Endothelial dysfunction also has prognostic implications and is associated with an increased risk of future cardiovascular events [21-23].”
Background
Protecting against vascular disease in brain
Faraci, F. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01310.2010 · Cited by 196
“Impairment of endothelium-dependent vasodilation is predictive of clinical events and stroke, independent of differences in arterial pressure (100, 116, 276, 281).”
Background
Detection and Treatment of Vulnerable Plaques and Vulnerable Patients
Waxman, S., Ishibashi, F., & Muller, J. E. (2006) · Circulation · doi:10.1161/circulationaha.105.540013 · Cited by 199
Unanswered Questions for Management of Acute Coronary Syndrome
Bugiardini, R., Manfrini, O., & Ferrari, G. M. D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1391 · Cited by 200
“special tests are not routinelyemployed, (ie, intravascular ultrasonography(9) and intracoronary acetylcholine testing).(10-13)”
Background
Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease
Schmidt, T. S., & Alp, N. J. (2007) · Clinical Science · doi:10.1042/cs20070108 · Cited by 195
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntané, J., Rocha, M., & Víctor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 208
“Despite its presence on the market for six decades now, this compound continues to intrigue researchers, especially due to mounting evidence of its effectiveness in other metabolic pathologies, such as obesity, PCOS [71], CVD [72], non-alcoholic fatty liver disease [73], premature puberty [74], kidney disease [75], T1…”
BackgroundInfluential
Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome
Britten, M. B., Zeiher, A. M., & Sch�chinger, V. (2004) · Coronary Artery Disease · doi:10.1097/01.mca.0000134590.99841.81 · Cited by 198
Endothelial Function
Vita, J. A. (2011) · Circulation · doi:10.1161/circulationaha.111.078824 · Cited by 195
Brugada syndrome: 1992–2002
Antzelevitch, C. N., Brugada, P., Brugada, J., Brugada, R., Towbin, J. A., & Nademanee, K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00310-3 · Cited by 193
Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
Lee, C. R., North, K. E., Bray, M. S., Fornage, M., Seubert, J. M., Newman, J. W. I., Hammock, B. D., Couper, D. J., HEISS, G. M., & Zeldin, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl085 · Cited by 196
“Endothelial dysfunction is typically manifested by impairment in endothelial-dependent vasodilation (4) and is associated with increased risk of acute cardiovascular events (3).”
Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities
Brocq, M. L. L., Leslie, S. J., Milliken, P. H., & Megson, I. L. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.2013 · Cited by 196
“Impaired endothelium-dependent coronary artery vasodilatation is associated with increased risk of subsequent vascular events (161, 414).”
The cardiovascular health benefits of apples: Whole fruit vs. isolated compounds
Bondonno, N. P., Bondonno, C. P., Ward, N. C., Hodgson, J. M., & Croft, K. D. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.04.012 · Cited by 192
“A significant association has been observed between endothelial dysfunction, often caused by a decrease in the bioavailability and/or bioactivity of the vasodilator nitric oxide (NO), and increased risk of CVD (Halcox et al., 2002).”
Background
Revisiting the mechanisms of ACE inhibitory peptides from food proteins
Wu, J., Liao, W., & Udenigwe, C. C. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.07.011 · Cited by 192
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
Lu, T. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.013 · Cited by 192
Is the Association Between Flow-Mediated Dilation and Cardiovascular Risk Limited to Low-Risk Populations?
Witte, D. R., Westerink, J., de Koning, E. J. P., van der Graaf, Y., Grobbee, D. E., & Bots, M. L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.073 · Cited by 191
“Invasive measures of endothelial function with a pharmacological stimulus have been found to be related to (24,25) in patients at medium or high risk.”
Recent Advances in Understanding Endothelial Dysfunction in Atherosclerosis
Yang, Z., & Ming, X. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.1.53 · Cited by 191
Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need
Ford, T. J., & Corcoran, D. S. (2017) · Heart · doi:10.1136/heartjnl-2017-311446 · Cited by 185
“39 Abnormal flow response to endothelial agonist can be assessed using symptoms and angiography alone (ie, >20% angiographic reduction in coronary luminal diameter during acetylcholine infusion), 31 intracoronary Doppler flow measurement or with thermodilution.”
Interactions Between Autonomic Nervous System Activity and Endothelial Function: A Model for the Development of Cardiovascular Disease
Harris, K. F., & Matthews, K. A. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000116719.95524.e2 · Cited by 182
“Additionally, non-CAD angiography patients who have abnormal coronary responses to acetylcholine are at an increased risk for subsequent CVD events (36).”
Background
Prognostic value of endothelial function
Quyyumi, A. A. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00430-2 · Cited by 183
Self-citation
Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
Maclay, J. D., McAllister, D., Mills, N. L., Paterson, F., Ludlam, C. A., Drost, E., Newby, D. E., & MacNee, W. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0414oc · Cited by 182
“Heart rate, bpm 68 (12) 58 (8) 0.002 Peripheral systolic blood pressure, mm Hg 128 (18) 130 (14) 0.673 Peripheral diastolic blood pressure, mm Hg 77 (11) 77 (9) 0.921 Peripheral pulse pressure, mm Hg 43 (14) 45 (11) 0.618 Mean arterial pressure, mm Hg 95 ( 13 ) 96 (10) 0.894 Central systolic blood pressure, mm Hg 120…”
Influential
Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations
GREEN, D. J., Walsh, J. H., Maiorana, A., Best, M. J., Taylor, R. R., & O'Driscoll, J. G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00519.2003 · Cited by 178
Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk
Anderson, T. J. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70990-4 · Cited by 178
“These studies have used coronary endothelial function testing (103-107), brachial impedance plethysmography (83,108) and brachial flow-mediated dilation (109-114).”
Method
Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome
Prasad, A., & Quyyumi, A. A. (2004) · Circulation · doi:10.1161/01.cir.0000141736.76561.78 · Cited by 176
Self-citation
The role of red and processed meat in colorectal cancer development: a perspective
Oostindjer, M., Alexander, J., Amdam, G. V., Andersen, G., Bryan, N. S., Chen, D., Corpet, D. E., SMET, S. D., Dragsted, L. O., Haug, A., et al. (2014) · Meat Science · doi:10.1016/j.meatsci.2014.02.011 · Cited by 187
Cardiac positron emission tomography imaging
Macháč, J. (2005) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.09.002 · Cited by 176
The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons
Farrah, T. E., Dhillon, B., Keane, P. A., Webb, D. J., & Dhaun, N. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.039 · Cited by 184
Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans
Koska, J., Sands, M., Burciu, C., D’Souza, K. M., Raravikar, K., Liu, J., Truran, S., Franco, D. A., Schwartz, E. A., Schwenke, D. C., et al. (2015) · Diabetes · doi:10.2337/db14-0976 · Cited by 174
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis
Yılmaz, A., Mahrholdt, H., Athanasiadis, A., Vogelsberg, H., Meinhardt, G., Voehringer, M. C., Kispert, E.-M., Deluigi, C., Baccouche, H., Spodarev, E., et al. (2008) · Heart · doi:10.1136/hrt.2007.131383 · Cited by 174
Mediterranean Dietary Patterns and Cardiovascular Health
Shen, J., Wilmot, K. A., Ghasemzadeh, N., Molloy, D. L., Burkman, G. M., Mekonnen, G., Góngora, M. C., Quyyumi, A. A., & Sperling, L. S. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-011215-025104 · Cited by 179
Self-citation
Dietary nitrite prevents hypercholesterolemic microvascular inflammation and reverses endothelial dysfunction
Stokes, K. Y., Dugas, T. R., Tang, Y., Garg, H., Guidry, E., & Bryan, N. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01291.2008 · Cited by 171
“Furthermore, endothelial dysfunction due to reduced NO bioavailability has been noted in arteries of patients with cardiovascular risk factors (29), which has important implications in their ability to perfuse tissues, in particular after an ischemic event.”
Background
Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action
Taubert, D., Berkels, R., Grosser, N., Schröder, H., Gründemann, D., & Schömig, E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705907 · Cited by 169
“Impaired NO-dependent endothelial function was recently found to be a strong predictor of cardiovascular events (Halcox et al., 2002; Targonski et al., 2003).”
Background
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Fonseca, V. A., Desouza, C. V., Asnani, S., & Jialal, I. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0034 · Cited by 169
Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease
Minami, Y., Satoh, M., Maesawa, C., Takahashi, Y., Tabuchi, T., Itoh, T., & Nakamura, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02110.x · Cited by 168
Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies
Daiber, A., & Chłopicki, S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.026 · Cited by 171
A Plant-Based Diet, Atherogenesis, and Coronary Artery Disease Prevention
Tuso, P. J., Stoll, S., & Li, W. W. (2014) · The Permanente Journal · doi:10.7812/tpp/14-036 · Cited by 183
Cardiac syndrome X: a critical overview and future perspectives
Lanza, G. A. (2005) · Heart · doi:10.1136/hrt.2005.067330 · Cited by 166
“The favourable prognosis of patients with CSX can be challenged by some recent data showing increased occurrence of events among patients with chest pain and normal or near normal coronary arteries who had evidence of coronary endothelial dysfunction.”
Background
Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis
Radico, F., Zimarino, M., Fulgenzi, F., Ricci, F., Nicola, M. D., Jespersen, L., Chang, S. M., Humphries, K. H., Marzilli, M., & Caterina, R. D. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy185 · Cited by 165
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Axtell, A. L., Gomari, F. A., & Cooke, J. P. (2010) · Journal of Visualized Experiments · doi:10.3791/2167 · Cited by 182
Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: The Northern Manhattan Study (NOMAS)
Suzuki, T., Hirata, K., Elkind, M. S. V., Jin, Z., Rundek, T., Miyake, Y., Boden-Albala, B. M., Tullio, M. R. D., Sacco, R. L., & Homma, S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.022 · Cited by 161
Assessment and pathophysiology of microvascular disease: recent progress and clinical implications
Masi, S., Rizzoni, D., Taddei, S., Widmer, R. J., Montezano, A. C. I., Lüscher, T. F., Schiffrin, E. L., Touyz, R. M., Paneni, F., Lerman, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa857 · Cited by 162
“Some reports, however, have described increased rates of clinical events in angina patients with non-obstructive coronary stenoses(120,121) or a relation between CMD and events.(9,122,123) The interpretation of these results is complicated by the recruitment of heterogeneous populations, in whom the role of CMD as an…”
Background
High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation
Munk, P. S., Staal, E. M., Butt, N., Isaksen, K., & Larsen, A. I. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.08.021 · Cited by 160
Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
Yubero‐Serrano, E. M., Fernández-Gandara, C., García‐Ríos, A., Rangel-Zúñiga, O. A., Gutierrez-Mariscal, F. M., Torres-Peña, J. D., Marı́n, C., López-Moreno, J., Castano, J. P., Delgado‐Lista, J., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003282 · Cited by 169
“Endothelial dysfunction, a primary mechanism involved in the development of arteriosclerotic disease, is widely recognized as a significant predictor of cardiovascular risk [3, 4].”
Background
Usefulness of Brachial Artery Flow-Mediated Dilation to Predict Long-Term Cardiovascular Events in Subjects Without Heart Disease
Shechter, M., Shechter, A., Koren‐Morag, N., Feinberg, M. S., & Hiersch, L. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.051 · Cited by 160
Coronary Vasomotor Response to Intracoronary Acetylcholine Injection, Clinical Features, and Long‐term Prognosis in 873 Consecutive Patients With Coronary Spasm: Analysis of a Single‐Center Study Over 20 Years
Sato, K., Kaikita, K., Nakayama, N., Horio, E., Yoshimura, H., Ono, T., Ohba, K., Tsujita, K., Kojima, S., Tayama, S., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000227 · Cited by 160
Smoking and endothelial function
Puranik, R., & Celermajer, D. S. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.ypcad13 · Cited by 157
Soluble guanylate cyclase: a potential therapeutic target for heart failure
Gheorghiade, M., Marti, C. N., Sabbah, H. N., Roessig, L., Greene, S. J., Böhm, M., Burnett, J. C. J., Campia, U., Cleland, J. G. F., Collins, S. P., et al. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9323-1 · Cited by 159
“In patients with and without coronary disease, epicardial or microvascular endothelial dysfunction predicts death, myocardial infarction, stroke, and hospitalizations [45–50].”
Background
The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis
Brainin, P., Frestad, D., & Prescott, E. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.052 · Cited by 155
Risk for subsequent coronary artery disease after preeclampsia
Haukkamaa, L., Salminen, M., Laivuori, H. M., Leinonen, H., Hiilesmaa, V. K., & Kaaja, R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.11.065 · Cited by 154
Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events
Schindler, T. H., Nitzsche, E. U., Schelbert, H. R., Olschewski, M., Sayre, J., Mix, M., Brink, I., Zhang, X.-L., Kreissl, M., Magosaki, N., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.040 · Cited by 149
“This otion is supported by findings in the clinical assessment of oronary vascular function (3,4), which have demonstrated hat, even in the presence of atherosclerosis, endothelial ysfunction of the coronary circulation remains an indepenent predictor of disease progression and cardiovascular vents.”
BackgroundMethodResultInfluential
Endothelial Dysfunction Induced by Post-Prandial Lipemia
Tyldum, G. A., Schjerve, I. E., Tjønna, A. E., Kirkeby‐Garstad, I., Stølen, T., Richardson, R. S., & Wisløff, U. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.033 · Cited by 152
“Impaired endothelial function is central to the atherosclerotic disease process and serves as a strong independent risk factor for future cardiovascular disease and mortality ( 1 ,2).”
Background
Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis
Siasos, G., Sara, J. D. S., Zaromytidou, M., Park, K. H., Coskun, A. U., Lerman, L. O., Oikonomou, E. K., Maynard, C. C., Fotiadis, D., Stefanou, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.073 · Cited by 151
Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta‐analysis
Schwarz, E. I., Puhan, M. A., Schlatzer, C., Stradling, J. R., & Kohler, M. (2015) · Respirology · doi:10.1111/resp.12573 · Cited by 150
The effect of physical activity on endothelial function in man
Moyna, N. M., & Thompson, P. D. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.0001-6772.2003.01253.x · Cited by 148
Green tea (Camellia sinensis) catechins and vascular function
Moore, R. J., Jackson, K. G., & Minihane, A. M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509991218 · Cited by 149
Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease
Satoh, M., Ishikawa, Y., Takahashi, Y., Itoh, T., Minami, Y., & Nakamura, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.040 · Cited by 150
“The classic risk factors for atherosclerosis induce endothelial injury, and impaired endothelial function predicts the risks of subsequent cardiovascular events [ 19 ].”
Background
Stabilisation of atherosclerotic plaques
Bentzon, J. F., Daemen, M. J. A. P., Falk, E., Garcia-Garcia, H., Herrmann, J., Hoefer, I. E., Jukema, J. W., Krams, R., Kwak, B. R., Marx, N., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0784 · Cited by 150
Methods for Evaluating Endothelial Function in Humans
Barac, A., Campia, U., & Panza, J. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000259601.38807.a6 · Cited by 145
Clinical Utility of Endothelial Function Testing
Kuvin, J. T., & Karas, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000075928.54461.33 · Cited by 143
Endothelial dysfunction in human essential hypertension
Mordi, I. R., Mordi, N., Delles, C., & Tzemos, N. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000965 · Cited by 141
“Endothelial dysfunction has been shown to be an adverse prognostic indicator in several studies, for example, in patients with coronary artery disease [48,49], heart failure [50,51], and peripheral vascular disease [52].”
Erythritol is a sweet antioxidant
den Hartog, G. J. M., Boots, A. W., Adam‐Perrot, A., Brouns, F. J. P. H., Verkooijen, I., Weseler, A. R., Haenen, G. R. M. M., & Bast, A. (2009) · Nutrition · doi:10.1016/j.nut.2009.05.004 · Cited by 140
“Endothelial dysfunction is thought to play an important role in vascular diabetic complications or diabetic vasculopathy [28] and appears to be a stepping stone for atherosclerosis [29].”
Background
Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment
Macdonald, J. E., Kennedy, N., & Struthers, A. D. (2004) · Heart · doi:10.1136/hrt.2003.017368 · Cited by 140
Endothelial Dysfunction in Diabetes: Pathogenesis, Significance, and Treatment
Hamilton, S. J., & Watts, G. F. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.133 · Cited by 142
“(2002) [50] 308 Patients with and without”
BackgroundInfluential
Coronary Physiology Beyond Coronary Flow Reserve in Microvascular Angina
Gould, K. L., & Johnson, N. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.106 · Cited by 139
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Microvascular Angina and the Continuing Dilemma of Chest Pain With Normal Coronary Angiograms
Cannon, R. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.080 · Cited by 137
The Endothelium and Inflammation
Trepels, T., Zeiher, A. M., & Fichtlscherer, S. (2006) · Endothelium · doi:10.1080/10623320601061862 · Cited by 138
Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update
Kardasz, I., & Caterina, R. D. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01788.x · Cited by 135
Forearm reactive hyperemia and mortality in end-stage renal disease
London, G. M., Pannier, B., Agharazii, M., Guérin, A. P., Verbeke, F., & Marchais, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00434.x · Cited by 134
Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids
Krötz, F., Riexinger, T., Buerkle, M. A., Nithipatikom, K., GLOE, T. R., Sohn, H., Campbell, W. B., & Pohl, U. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000116219.09040.8c · Cited by 134
Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo
Seddon, M. D., Melikian, N., Dworakowski, R., Shabeeh, H., Jiang, B., Byrne, J., Casadei, B., Chowienczyk, P., & Shah, A. M. (2009) · Circulation · doi:10.1161/circulationaha.108.822205 · Cited by 133
Effects of white and red wine on endothelial function in subjects with coronary artery disease
Whelan, A. P., Sutherland, W. H. F., McCormick, M. P., Yeoman, D. J., de Jong, S. A., & Williams, M. J. A. (2004) · Internal Medicine Journal · doi:10.1111/j.1444-0903.2004.00507.x · Cited by 136
Particulate Matter Induces Translocation of IL-6 from the Lung to the Systemic Circulation
Kido, T., Tamagawa, E., Bai, N., Suda, K., Yang, H.-H. C., Li, Y., Chiang, G., Yatera, K., Mukae, H., Sin, D. D., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0427oc · Cited by 134
Endothelial dysfunction in obesity: etiological role in atherosclerosis
Meyers, M. R., & Gokce, N. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282be90a8 · Cited by 134
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms
Schindler, T. H., Hornig, B., Buser, P. T., Olschewski, M., Magosaki, N., Pfisterer, M. E., Nitzsche, E. U., Solzbach, U., & Just, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000057571.03012.f4 · Cited by 132
Hypoxia and Reoxygenation Induce Endothelial Nitric Oxide Synthase Uncoupling in Endothelial Cells through Tetrahydrobiopterin Depletion and S-Glutathionylation
De Pascali, F., Hemann, C., Samons, K., Chen, C.-A., & Zweier, J. L. (2014) · Biochemistry · doi:10.1021/bi500076r · Cited by 131
Inorganic nitrite and nitrate: evidence to support consideration as dietary nutrients
Bryan, N. S., & Ivy, J. L. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.06.001 · Cited by 131
“Further studies demonstrate that insufficient NO production is not only associated with all major cardiovascular risk factors, such as hyperlipidemia, diabetes, hypertension, smoking, and severity of atherosclerosis, but also has a profound predictive value for the future atherosclerotic disease progression [17-19].”
Background
Nitric Oxide Availability as a Marker of Oxidative Stress
Pierini, D., & Bryan, N. S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1441-8_5 · Cited by 128
Neuronal Nitric Oxide Synthase Regulates Basal Microvascular Tone in Humans In Vivo
Seddon, M. D., Chowienczyk, P. J., Brett, S. E., Casadei, B., & Shah, A. M. (2008) · Circulation · doi:10.1161/circulationaha.107.744540 · Cited by 129
Bioresorbable Scaffold Technologies
Onuma, Y., Ormiston, J. A., & Serruys, P. W. J. C. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1135 · Cited by 129

Authors: Halcox, J. P. J., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. A., & Quyyumi, A. A.
Affiliations: National Institutes of Health (US)
ORCID: Halcox, Julian P.J.
Prasad, Abhiram
Quyyumi, Arshed A.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-08-06
Volume: 106
Issue: 6
Pages: 653-658
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000025404.78001.d8
OpenAlex: W2019338486
Cited by: 1,385
References: 24
Citations by year: 2026: 12 · 2025: 13 · 2024: 25 · 2023: 33 · 2022: 21 · 2021: 33 · 2020: 49 · 2019: 50 · 2018: 56 · 2017: 51 · 2016: 51 · 2015: 70 · 2014: 87 · 2013: 59 · 2012: 70
FWCI: 51.48
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: coronary endothelial dysfunction, coronary artery disease, acetylcholine provocation test, sodium nitroprusside, adenosine, coronary vascular resistance, cardiovascular events, prognosis, myocardial infarction, unstable angina, stroke, cardiovascular mortality, revascularization
MeSH terms: Angina, Unstable, Coronary Artery Disease, Coronary Circulation, Coronary Vessels, Endothelium, Vascular, Female, Follow-Up Studies, Humans, Male, Microcirculation, Middle Aged, Myocardial Infarction, Pericardium, Prognosis, Vascular Resistance, Vasodilator Agents, Disease-Free Survival, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic Value of Coronary Vascular Endothelial Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks